Prevest Denpro [PREVEST] vs Dr Agarwal's Health [AGARWALEYE] Detailed Stock Comparison
Prevest Denpro
BSE
Loading...
Dr Agarwal's Health
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Prevest Denpro wins in 10 metrics, Dr Agarwal's Health wins in 6 metrics, with 0 ties. Prevest Denpro appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Prevest Denpro | Dr Agarwal's Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 36.86 | 625.56 | Prevest Denpro |
| Price-to-Book Ratio | 6.35 | 7.45 | Prevest Denpro |
| Debt-to-Equity Ratio | 0.00 | 49.87 | Prevest Denpro |
| EV/EBITDA | 26.13 | 31.57 | Prevest Denpro |
| Profit Margin (TTM) | 28.81% | 4.88% | Prevest Denpro |
| Operating Margin (TTM) | 32.92% | 15.34% | Prevest Denpro |
| EBITDA Margin (TTM) | 32.92% | 15.34% | Prevest Denpro |
| Return on Equity | 18.70% | 6.61% | Prevest Denpro |
| Return on Assets (TTM) | 12.17% | 4.39% | Prevest Denpro |
| Free Cash Flow (TTM) | $128.49M | $394.30M | Dr Agarwal's Health |
| 1-Year Return | 3.30% | 10.98% | Dr Agarwal's Health |
| Price-to-Sales Ratio (TTM) | 10.63 | 8.21 | Dr Agarwal's Health |
| Enterprise Value | $5.77B | $144.09B | Dr Agarwal's Health |
| EV/Revenue Ratio | 9.16 | 8.42 | Dr Agarwal's Health |
| Gross Profit Margin (TTM) | 86.70% | N/A | N/A |
| Revenue per Share (TTM) | $53 | $57 | Dr Agarwal's Health |
| Earnings per Share (Diluted) | $15.14 | $0.71 | Prevest Denpro |
| Beta (Stock Volatility) | 0.51 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Prevest Denpro vs Dr Agarwal's Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Prevest Denpro | -0.54% | 1.45% | 3.87% | 15.53% | 14.34% | -7.00% |
| Dr Agarwal's Health | 0.76% | -2.02% | 4.44% | 21.23% | 9.67% | 11.09% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Prevest Denpro | 3.30% | 65.82% | 110.57% | 110.57% | 110.57% | 110.57% |
| Dr Agarwal's Health | 10.98% | 10.98% | 10.98% | 10.98% | 10.98% | 10.98% |
Performance & Financial Health Analysis: Prevest Denpro vs Dr Agarwal's Health
| Metric | PREVEST | AGARWALEYE |
|---|---|---|
| Market Information | ||
| Market Cap | ₹6.70B | ₹140.42B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 5,120 | 268,372 |
| 90 Day Avg. Volume | 12,460 | 284,346 |
| Last Close | ₹555.00 | ₹449.60 |
| 52 Week Range | ₹393.60 - ₹686.00 | ₹327.00 - ₹494.50 |
| % from 52W High | -19.10% | -9.08% |
| All-Time High | ₹686.00 (Jan 13, 2025) | ₹494.50 (Jul 30, 2025) |
| % from All-Time High | -19.10% | -9.08% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.32% |
| Quarterly Earnings Growth | 0.08% | -0.16% |
| Financial Health | ||
| Profit Margin (TTM) | 0.29% | 0.05% |
| Operating Margin (TTM) | 0.33% | 0.15% |
| Return on Equity (TTM) | 0.19% | 0.07% |
| Debt to Equity (MRQ) | 0.00 | 49.87 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹87.89 | ₹59.60 |
| Cash per Share (MRQ) | ₹54.61 | ₹16.66 |
| Operating Cash Flow (TTM) | ₹148.17M | ₹3.60B |
| Levered Free Cash Flow (TTM) | ₹106.82M | ₹-474,997,504 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Prevest Denpro vs Dr Agarwal's Health
| Metric | PREVEST | AGARWALEYE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 36.86 | 625.56 |
| Forward P/E | N/A | 83.41 |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | 10.63 | 8.21 |
| Price to Book (MRQ) | 6.35 | 7.45 |
| Market Capitalization | ||
| Market Capitalization | ₹6.70B | ₹140.42B |
| Enterprise Value | ₹5.77B | ₹144.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.16 | 8.42 |
| Enterprise to EBITDA | 26.13 | 31.57 |
| Risk & Other Metrics | ||
| Beta | 0.51 | N/A |
| Book Value per Share (MRQ) | ₹87.89 | ₹59.60 |
Financial Statements Comparison: Prevest Denpro vs Dr Agarwal's Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PREVEST | AGARWALEYE |
|---|---|---|
| Revenue/Sales | ₹184.55M | N/A |
| Cost of Goods Sold | ₹24.54M | N/A |
| Gross Profit | ₹160.01M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹60.76M | N/A |
| EBITDA | ₹76.23M | N/A |
| Pre-Tax Income | ₹71.51M | N/A |
| Income Tax | ₹20.16M | N/A |
| Net Income (Profit) | ₹51.41M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PREVEST | AGARWALEYE |
|---|---|---|
| Cash & Equivalents | ₹608.98M | ₹1.04B |
| Total Current Assets | ₹857.16M | ₹7.94B |
| Total Current Liabilities | ₹59.62M | ₹4.78B |
| Long-Term Debt | ₹0 | ₹8.08B |
| Total Shareholders Equity | ₹1.06B | ₹19.27B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹268.13M | ₹13.40B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PREVEST | AGARWALEYE |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PREVEST | AGARWALEYE |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 5,120 | 268,372 |
| Average Daily Volume (90 Day) | 12,460 | 284,346 |
| Shares Outstanding | 12.00M | 315.88M |
| Float Shares | 2.61M | N/A |
| % Held by Insiders | 0.78% | 0.76% |
| % Held by Institutions | 0.00% | 0.16% |
Dividend Analysis & Yield Comparison: Prevest Denpro vs Dr Agarwal's Health
| Metric | PREVEST | AGARWALEYE |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |